Targeting Post-Translational Modifications of Huntingtin to treat Huntington disease
Targeting Post-Translational Modifications of Huntingtin to treat Huntington disease
靶向亨廷顿蛋白的翻译后修饰来治疗亨廷顿病
批准号：
396825
负责人：
Lemarie Fanny L
金额：
$9.83万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-11-01 至 2021-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Huntington disease is an inherited degenerative brain disorder that affects 1 in 7,500 individuals in the Western world. It is characterised by involuntary movements, cognitive deficits, and dementia leading ultimately to death. The cause of Huntington di
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
